Health
Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants – News-Medical.Net
A new monoclonal antibody targets a particular region of the RBD on the SARS-CoV-2. This region is usually not accessible to immune cells, which may be why it has…
A new monoclonal antibody targets a particular region of the receptor-binding domain (RBD) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This region is usually not accessible to immune cells, which may be why it has broad neutralizing capabilities.
With the coronavirus disease 2019 (COVID-19) pandemic continuing around the globe, new mutants of SARS-CoV-2 are emerging. These new variants are likely more infectious and can better evade our immune response.
The SARS-CoV-2…
-
General14 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business23 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business22 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General22 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips